Condition Focus: Osteoarthritis — Cartilage Restoration and Chronic Pain Reduction

This study from Balbinot and colleagues, published in the specialised journal Cartilage, is notable for demonstrating two effects simultaneously: cartilage structural repair and chronic pain reduction. Most studies measure one or the other. By showing both in the same animals, this study establishes that PBM’s tissue-repair effects translate to functional benefit — the repaired cartilage is not just histologically improved but contributes to measurable pain relief.

Using a monoiodoacetate (MIA)-induced knee OA model — which produces progressive cartilage degradation and chronic pain behaviours similar to human OA — the researchers demonstrated that PBM partially restored proteoglycan and collagen content in the damaged cartilage. Proteoglycans are the molecules that give cartilage its compressive strength and shock-absorbing capacity, while collagen provides tensile strength and structural integrity.

The pain reduction operated through dual mechanisms: peripheral (at the joint level, through anti-inflammatory and tissue-repair effects) and central (at the spinal cord level, through modulation of glial cell activation). This dual-mechanism pain relief is relevant to gout because chronic gout patients often develop central sensitisation — a state where the spinal cord and brain amplify pain signals even beyond what the peripheral inflammation warrants.

G.O.A.T. for Gout Alignment:
The dual mechanism — cartilage repair at the joint plus central pain modulation at the spinal level — supports the G.O.A.T.’s application for both acute flare management and chronic gout joint maintenance. The proteoglycan and collagen restoration demonstrated here is directly relevant to the progressive cartilage damage seen in recurrent gout.

Link to original research here

Editor’s note: The cartilage matrix restoration here complements the human chondrocyte ColII/Aggrecan data in Oliveira et al 2025. The chronic pain model parallels gout chronicity better than acute pain studies. The central sensitisation component connects to the systemic anti-inflammatory effects demonstrated in Shamloo et al 2023. For the MMP-13 suppression that protects against cartilage breakdown, see Nambi 2021.

Related Articles

• NIR PBM Stimulates Cartilage Matrix Synthesis in Human Chondrocytes – Oliveira et al 2025
• PBM Suppresses NLRP3 Inflammasome Outputs with Dual Wavelength – Shamloo et al 2023
• LLLT Effects on Inflammatory Biomarkers in OA: Meta-Analysis – Nambi 2021
• PBM, Cells of Connective Tissue and Repair – Houreld et al 2022
• PBM in Promoting Cartilage Regeneration – 2025

Key Takeaways

• PBM partially restored proteoglycan and collagen content in damaged cartilage
• Chronic pain reduced through dual peripheral (joint) and central (spinal) mechanisms
• MIA chronic pain model more closely parallels chronic gout than acute models
• Published in Cartilage — a specialised journal focused on cartilage biology and repair

Study Overview

Full Citation

Balbinot G, et al. (2021). Photobiomodulation partially restores cartilage integrity and reduces chronic pain behaviour in a rat model of osteoarthritis. Cartilage, 13(2_suppl), 1309S–1321S. View Publication